Hyperfractionated accelerated radiation therapy for nonsmall cell lung cancer: Clinical phase trial
Author:
Publisher
Elsevier BV
Subject
Cancer Research,Radiology Nuclear Medicine and imaging,Oncology,Radiation
Reference9 articles.
1. A randomized phase III trial of hyperfractionated radiation therapy with total dose of 60.0 Gy to 79.2 Gy: Possible survival benefit with ≥69.6 Gy in favorable patients with RTOG stage III non small cell lung cancer: Report of RTOG 83-11;Cox;J. Clin. Oncol.,1990
2. Clinical dose-response curves of human malignant epithelial tumors;Fletcher;Br. J. Radiol.,1973
3. Hyperfractionated irradiation for non small cell lung cancer;Fu;Clin. J. Oncol.,1994
4. Three dimensional radiotherapy for nonsmall cell lung cancer. The Washington University experience (Abstr);Graham,1996
5. Initial experience with practical hyperfractionated accelerated radiation therapy regimen;Herskovic;Int. J. Radiat. Oncol. Biol. Phys.,1991
Cited by 31 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. "A Comparative Study Using Conventional Concomitant Chemoradiotherapy (Using Cisplatin-Based Chemotherapy) with Accelerated (Six Fractions a Week) Chemoradiotherapy in Inoperable or Nonresectable Locally Advanced Non-small Cell Lung Cancers:" A Prospective Randomized Trial;CLIN CANCER INVESTIG;2021
2. Predictors of Acute Radiation Esophagitis in Non-small Cell Lung Cancer Patients Treated With Accelerated Hyperfractionated Chemoradiotherapy;Anticancer Research;2018-12-27
3. Radiation Dose Escalation in Accelerated Hyperfractionated Radiotherapy for Stage III Non-small-cell Lung Cancer;Anticancer Research;2018-10
4. Long-term quality of life in inoperable non-small cell lung cancer patients treated with conventionally fractionated compared to hyperfractionated accelerated radiotherapy – Results of the randomized CHARTWEL trial;Radiotherapy and Oncology;2018-02
5. Accelerated hypofractionated radiotherapy for advanced lung cancer;Journal of Radiotherapy in Practice;2017-06-27
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3